Cáncer de mama en hombres. ¿Es una entidad diferente al cáncer de mama en la mujer? Revisión de la literatura

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-917.

https://doi.org/10.1002/ijc.25516

Ly D, Forman D, Ferlay J, Brinton LA, Cook MB. An international comparison of male and female breast cancer incidence rates. Int J Cancer. 2012.

https://doi.org/10.1002/ijc.27841

Instituto Nacional de Cancerología. Anuario Estadístico 2010. Instituto Nacional de Cancerología Colombia; 2012 September 4 [consultado 4 Sep 2012]. Disponible en: URL: http://www.cancer.gov.co/documentos/Anuario%20Estaditico/2010/Anuario%20Impreso2010.pdf

Chavez-MacGregor M, Clarke CA, Lichtensztajn D, Hortobagyi GN, Giordano SH. Male breast cancer according to tumor subtype and race. Cancer. 2013;119(9):1611-7.

https://doi.org/10.1002/cncr.27905

Anderson WF, Jatoi I, Tse J, Rosenberg PS. Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol. 2010;28(2):232-9.

https://doi.org/10.1200/JCO.2009.23.8162

Proyecto de investigación ACM1 [consultado 28 Mar 2014]. Disponible en: URL: http://www.mastologiacolombia.com/userfiles/file/06-03-2013/Presentacion%20Proyecto%20ACM1.pdf

Abad JFR, Mallarino JJC, Suarez RdA. Análisis de sobrevida en una cohorte de 1328 pacientes con carcinoma de seno. Rev Col Cirugia. 2005;20(1):4-20.

Kao L, Bulkin Y, Fineberg S, Montgomery L, Koenigsberg T. A case report: lobular carcinoma in situ in a male patient with subsequent invasive ductal carcinoma identified on screening breast MRI. J Cancer. 2012;3:226-30.

https://doi.org/10.7150/jca.4091

Korde LA, Zujewski JA, Kamin L, Giordano S, Domchek S, Anderson WF, et al. Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol. 2010;28(12):2114-22.

https://doi.org/10.1200/JCO.2009.25.5729

Deb S, Jene N, Fox SB. Genotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas. BMC cancer. 2012;12(1):510.

https://doi.org/10.1186/1471-2407-12-510

Otto F. Male breast cancer GC ̧ö neglected tumour. European journal of cancer Oxford, England;. 1990;47:S340-1, 1-9-2011.

Plevova P, Hladikova A. Genetic counselling in male carriers of BRCA1 and BRCA2 gene mutations. Klin Onkol. 2012;25 Suppl:S67-73.

https://doi.org/10.1016/S0959-8049(11)70195-2

Vodusek AL, Novakovic S, Stegel V, Jereb B. Genotyping of BRCA1, BRCA2, p53, CDKN2A, MLH1 and MSH2 genes in a male patient with secondary breast cancer. Radiol Oncol. 2011;45(4):296-9.

https://doi.org/10.2478/v10019-011-0031-6

Basham VM, Lipscombe JM, Ward JM, Gayther SA, Ponder BA, Easton DF, et al. BRCA1 and BRCA2 mutations in a populationbased study of male breast cancer. Breast Cancer Research. 2001;4(1):R2.

https://doi.org/10.1186/bcr419

Dabakuyo TS, Dialla O, Gentil J, Poillot ML, Roignot P, Cuisenier J, et al. Breast cancer in men in Cote d'Or (France): epidemiological characteristics, treatments and prognostic factors. Eur J Cancer Care (Engl). 2012;21(6):809-16.

https://doi.org/10.1111/j.1365-2354.2012.01365.x

Kornegoor R, Verschuur-Maes AH, Buerger H, Hogenes MC, de Bruin PC, Oudejans JJ, et al. Molecular subtyping of male breast cancer by immunohistochemistry. Modern Pathology. 2011;25(3):398-404.

https://doi.org/10.1038/modpathol.2011.174

Yu XF, Feng WL, Miao LL, Chen B, Yang HJ. The prognostic significance of molecular subtype for male breast cancer: A 10-year retrospective study. The Breast. 2013.

https://doi.org/10.1016/j.breast.2013.02.005

Johansson I, Nilsson C, Berglund P, Strand C, Jönsson G, Staaf J, et al. High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer. Breast Cancer Res Treat. 2011;129(3):747-60.

https://doi.org/10.1007/s10549-010-1262-8

Johansson I, Nilsson C, Berglund P, Lauss M, Ringnér M, Olsson H., et al. Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies Nacetyltransferase-1 (NAT1) as a novel prognostic biomarker. Breast Cancer Res. 2012;14(1):R31.

https://doi.org/10.1186/bcr3116

Nilsson C, Johansson I, Ahlin C, Thorstenson S, Amini RM, Holmqvist M, et al. Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact. Acta Oncol. 2012.

https://doi.org/10.3109/0284186X.2012.711952

Nilsson C, Koliadi A, Johansson I, Ahlin C, Thorstenson S, Bergkvist L, et al. High proliferation is associated with inferior outcome in male breast cancer patients. Mod Pathol. 2013;26(1):87-94.

https://doi.org/10.1038/modpathol.2012.145

Yokoyama J, Kobayashi T, Nakamura T, Nakajima Y. A case of male breast cancer in which oncotype DX was used to determine the therapeutic strategy. Gan to kagaku ryoho Cancer & chemotherapy. 2012;39(12):2057-9.

Henry LR, Stojadinovic A, Swain SM, Prindiville S, Cordes R, Soballe PW. The influence of a gene expression profile on breast cancer decisions. Journal of surgical oncology. 2009;99(6):319-23.

https://doi.org/10.1002/jso.21244

Shak S, Palmer G, Baehner FL, Millward C, Watson D, Sledge Jr GW. Molecular characterization of male breast cancer by standardized quantitative RT-PCR analysis: First large genomic study of 347 male breast cancers compared to 82,434 female breast cancers. J ClinOncol (Meeting Abstracts). 2009;27(15S):549.

Kiluk JV, Lee MC, Park CK, Meade T, Minton S, Harris E, et al. Male Breast Cancer: Management and Follow-up Recommendations. The Breast Journal. 2011;17(5):503-9.

https://doi.org/10.1111/j.1524-4741.2011.01148.x

Cloyd J, Hernandez-Boussard T, Wapnir I. Outcomes of Partial Mastectomy in Male Breast Cancer Patients: Analysis of SEER, 1983GC ̧ô2009. Ann Surg Oncol. 2013;20(5):1545-50.

https://doi.org/10.1245/s10434-013-2918-5

Cloyd J, Hernandez-Boussard T, Wapnir I. Poor compliance with breast cancer treatment guidelines in men undergoing breast-conserving surgery. Breast Cancer Res Treat. 2013;139(1):177-82.

https://doi.org/10.1007/s10549-013-2517-y

Lanitis S, Filippakis G, Al Mufti R, Hadjiminas D. Breast conserving surgery with preservation of the nipple-areola complex as a feasible and safe approach in male breast cancer: a case report. Journal of Medical Case Reports. 2008;2(1):126.

https://doi.org/10.1186/1752-1947-2-126

Giordano SH. A review of the diagnosis and management of male breast cancer. Oncologist. 2005;10(7):471-9.

https://doi.org/10.1634/theoncologist.10-7-471

Gentilini O, Chagas E, Zurrida S, Intra M, De CC, Gatti G, et al. Sentinel lymph node biopsy in male patients with early breast cancer. Oncologist. 2007;12(5):512-5.

https://doi.org/10.1634/theoncologist.12-5-512

Flynn LW, Park J, Patil SM, Cody III HS, Port ER. Sentinel lymph node biopsy is successful and accurate in male breast carcinoma. J Am Coll Surg. 2008;206(4):616-21.

https://doi.org/10.1016/j.jamcollsurg.2007.11.005

De CC, Baio SM, Veronesi P, Trifiro G, Ciprian A, Vento A, et al. Sentinel node biopsy in male breast cancer. Nucl Med Commun. 2004;25(2):139-43.

https://doi.org/10.1097/00006231-200402000-00008

Zygogianni AG, Kyrgias G, Gennatas C, Ilknur A, Armonis V, Tolia M, et al. Male breast carcinoma: epidemiology, risk factors and current therapeutic approaches. Asian Pac J Cancer Prev. 2012;13(1):15-9.

https://doi.org/10.7314/APJCP.2012.13.1.015

Stranzl H, Mayer R, Quehenberger F, Prettenhofer U, Willfurth P, Stöger H, et al. Adjuvant radiotherapy in male breast cancer. Radiotherapy and Oncology. 1999;53(1):29-35.

https://doi.org/10.1016/S0167-8140(99)00122-X

Zabel A, Milker-Zabel S, Zuna I, Wannenmacher M, Debus J. External beam radiotherapy in the treatment of male breast carcinoma: patterns of failure in a single institute experience. Tumori. 2005;91(2):151-5.

https://doi.org/10.1177/030089160509100209

Giordano SH, Perkins GH, Broglio K, Garcia SG, Middleton LP, Buzdar AU, et al. Adjuvant systemic therapy for male breast carcinoma. Cancer. 2005;104(11):2359-64.

https://doi.org/10.1002/cncr.21526

Gnant M, Harbeck N. Thomssen C. St. Gallen 2011: Summary of the Consensus Discussion. Breast Care (Basel). 2011;6(2):136-41.

https://doi.org/10.1159/000328054

Ribeiro G, Swindell R. Adjuvant tamoxifen for male breast cancer (MBC). Br J Cancer. 1992;65(2):252-4.

https://doi.org/10.1038/bjc.1992.50

Goss PE, Reid C, Pintilie M, Lim R, Miller N. Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer. 1999;85(3):629-39.

https://doi.org/10.1002/(SICI)1097-0142(19990201)85:3<629::AID-CNCR13>3.0.CO;2-V

Giordano SH, Valero V, Buzdar AU, Hortobagyi GN. Efficacy of anastrozole in male breast cancer. Am J Clin Oncol. 2002;25(3):235-7.

https://doi.org/10.1097/00000421-200206000-00006